Advances in Cancer Immunotherapies (ACI) 2014

ASTRIK’s Advances in Cancer Immunotherapies 2014 looks at key market drivers and factors impacting growth on the adoption of immunotherapy strategies, and how its expanding use against cancer is delivering healthcare solutions that hold new therapeutic promises for cancer patients. ACI2014’s stellar panel of speakers from the biomedical research, healthcare and biopharmaceutical sectors will discuss the latest and future developments in immunotherapy research; review the therapeutic potentials of cancer immunotherapies and targeted therapies; and examine the challenges as well as opportunities accompanying this new generation of innovative biopharmaceuticals fuelling growth in the oncology market.

Key Topics Include
New approaches and strategies to optimize cancer immunotherapy
Monoclonal antibodies in cancer targeted therapy
Anti-cancer vaccines in preventive medicine
Immunogene therapy
Immunomodulatory agents in cancer
Combination therapies and non-specific immunotherapies
Recent advances and future applications in cancer therapy

Registration Fees
Standard rate: SGD1,050
Academic rate (only applicable to local academic and research institutes): SGD650